The HIV In-home Test Tax Exemption Amendment Act of 2025 aims to exempt sales of HIV in-home tests from taxation in the District of Columbia. This legislation recognizes the importance of accessible HIV testing as a public health measure, particularly given the significant costs associated with these tests, which range from $40 to $70. By removing the tax burden, the bill seeks to enhance the availability of these tests, thereby promoting early detection and treatment of HIV, which is crucial for preventing the spread of the virus.

The bill specifically amends section 47-2005 of the District of Columbia Official Code by adding a new paragraph that states, "Sales of human immunodeficiency virus (HIV) in-home tests" will be exempt from taxation. This legislative effort is supported by multiple council members and follows a similar proposal introduced in the previous council period. The act will take effect once it is included in an approved budget and financial plan, and after the necessary legislative processes are completed.